'Uncategorized' Category
By Simmons Hanly Conroy | August 31, 2012
Study Links Propecia to Depression
A new study recently published in the Journal of Clinical Psychiatry reports that hair-loss drug finasteride (Propecia) may be linked to more than just permanent sexual side effects. The study found that… Read More
By Simmons Hanly Conroy | July 13, 2012
New study: hair-loss drug Propecia’s side effects may be permanent
As we reported this morning, Propecia has been a topic of interest on the Today Show, and most recently Good Morning America. The Good Morning America segment on ABC discussed the negative side effects of… Read More
By Simmons Hanly Conroy | June 27, 2012
University of Pennsylvania's Treatment of Mesothelioma Showing Promising Results for Patients
Simmons Hanly Conroy Proud To Support Penn Mesothelioma Program Dr. Joseph S. Friedberg, head of UPenn’s Mesothelioma program, recently had a study published that includes some good news for mesothelioma patients. The… Read More
By Simmons Hanly Conroy | June 12, 2012
TODAY Reports on Propecia Links to Sexual Dysfunction
This morning the TODAY show reported on a new study that links the hair loss drug Propecia with sexual dysfunction. The study was conducted by Dr. Michael Irwig at George Washington University… Read More
By Simmons Hanly Conroy | June 6, 2012
Actos News and Information Updates for June
The Actos lawyers at the Firm are diligently monitoring information about the type 2 diabetes drug, Actos. We encourage you to learn more about the serious side effects, risks and legal options… Read More
By Simmons Hanly Conroy | May 15, 2012
FDA Label Requirements Fail Consumers Harmed by Generic Defective Drugs
Generic Drug Manufacturers Should Have a Duty to Warn Consumers of New Safety Concerns Generic drugs account for seventy-five percent of filled prescriptions. Buying generic saves money and, often, the drug is… Read More
By Simmons Hanly Conroy | April 10, 2012
FDA Requires Labels of Drospirenone Birth Control, Like Yaz, to Include Increased Blood Clot Risk Warning
The requirements levied against Bayer and its popular birth control Yaz became stricter today. The Food & Drug Administration has issued a safety alert regarding birth control that contains drospirenone, like Yaz and Yasmine,… Read More
By Simmons Hanly Conroy | March 26, 2012
U.S. Regulators Want FDA More Involved with Hip Replacements, Transvaginal Mesh and Other Faulty Medical Devices
Simmons Hanly Conroy is no longer accepting Hip Replacements cases. Bloomberg reports that four Democratic lawmakers, led by Edward Markey of Massachusetts, have issued a bill that would give the FDA the ability… Read More
By Simmons Hanly Conroy | March 19, 2012
Faulty Hip Implants Can Cause Issues Even After Removal
Simmons Hanly Conroy is no longer accepting Hip Replacements cases. A February 2, 2012 article entitled, “Faulty hip implants may cause long-term health, joint damage,” by Janice Lloyd, published on yourlife.usatoday.com, reports… Read More
By Simmons Hanly Conroy | March 6, 2012
Qnexa: Should A Weight Loss Drug with Topamax and Phentermine Get Approval Before Testing? Consumer Reports Weighs In
A ConsumerReports.org article disagrees with experts who recently voted in an overwhelming majority that the Food and Drug Administration should approve the weight loss drug Qnexa and postpone important studies to monitor it for… Read More
